Hims and Hers
Last updated July 14, 2026 · Independent guide · Not medical advice
What is Hims and Hers?
Hims and Hers is a single publicly traded telehealth company — formally Hims & Hers Health, Inc. — that runs two consumer brands under one roof: Hims for men’s health and Hers for women’s health. Both connect people with licensed clinicians online and deliver treatments to the door on a subscription. So when people say “Hims and Hers,” they are usually describing the combined business rather than two separate companies. It is one parent, two tailored front doors.
The company launched in 2017, starting with the men’s-focused Hims brand, then grew to include Hers and a wider set of categories. In 2021 it became publicly listed, and today it trades on the NYSE. For the individual brand explainers, see What Is Hims for the men’s side and Hers for the women’s side.
How are the two brands related?
The relationship is best understood as shared infrastructure with different storefronts. Both brands use the same core model — online intake, clinician review, and auto-renewing subscriptions — but serve different audiences and product mixes.
| Hims | Hers | |
|---|---|---|
| Audience | Men’s health | Women’s health |
| Signature offerings | Hair loss, ED | Birth control, hair and skin |
| Model | Online intake, clinician review, subscription | Same |
| Parent | Hims & Hers Health, Inc. | Hims & Hers Health, Inc. |
This structure lets the company reach a broad market while keeping each brand focused. It also means improvements to the platform, pharmacy network, or clinician model tend to benefit both brands at once.
What products span Hims and Hers?
Across the combined company, the catalog covers several health categories. The table maps the main ones; availability varies by state and evolves over time.
| Category | Representative treatments | Brand |
|---|---|---|
| Hair loss | Finasteride, minoxidil, ketoconazole shampoo, biotin | Both |
| Sexual health | Sildenafil, tadalafil, branded Viagra/Cialis | Hims |
| Weight management | Compounded or branded GLP-1 medications | Both |
| Mental health | Anxiety and depression care, therapy | Both |
| Skincare | Tretinoin, anti-aging formulas | Both |
| Birth control | Select oral contraceptives | Hers |
On weight management specifically, the company offers GLP-1 medications such as semaglutide. Some options are branded and FDA-approved, while compounded versions are not FDA-approved as finished formulations — a distinction worth understanding before starting, ideally with a clinician’s input. This article is educational and not medical advice.
The public company: what to know
Hims & Hers Health trades on the New York Stock Exchange under the ticker HIMS. It went public in 2021 through a merger with a special purpose acquisition company, or SPAC — a route several consumer companies used in that period. Being public means it files regular financial reports that investors and analysts scrutinize.
Because the business runs on recurring subscriptions, it generates repeat revenue across hair, sexual health, weight, mental health, skincare, and women’s care. That subscription dynamic is a big reason the stock draws attention. If you want the investing angle specifically, our Hims Stock page digs into how the market views the company. To be clear, none of this is investment advice; anyone weighing the stock should do independent research.
Who leads Hims and Hers?
The company was co-founded by Andrew Dudum, who has served as chief executive and become a recognizable public voice for the brand, often discussing its telehealth approach and expansion into new categories like weight loss. You can read more about his background on our Andrew Dudum profile. Leadership and strategy shift over time, so for the most current picture it is best to check the company’s own filings alongside independent coverage.
How does Hims and Hers make money?
The engine is subscriptions. Most treatments and care plans renew automatically on a set schedule, producing steady, repeat revenue rather than one-off sales. Spanning two brands and multiple categories broadens that base. For customers, the same model that keeps treatments uninterrupted also means auto-renewal is the default — a common source of complaints in Hims Reviews, where forgotten renewals come up often. Tracking billing dates and knowing how to cancel is the practical takeaway.
The bottom line
Hims and Hers is one NYSE-listed telehealth company operating two brands: Hims for men and Hers for women. It shares a clinician-review platform and a subscription model across both, spanning hair, sexual health, weight, mental health, skincare, and women’s care. Founded in 2017 and public since 2021 under co-founder and CEO Andrew Dudum, it earns primarily through recurring subscriptions. For the full picture, start at the Hims hub — and remember this is educational content, not medical or investment advice.